Estabrook Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-69
Closed -$894 323
2019
Q1
$894 Hold
69
﹤0.01% 314
2018
Q4
$1.04K Sell
69
-61
-47% -$1.58K ﹤0.01% 313
2018
Q3
$5.11K Sell
130
-35
-21% -$1.58K ﹤0.01% 320
2018
Q2
$8.12K Sell
165
-23
-12% -$1.3K ﹤0.01% 318
2018
Q1
$11.2K Hold
188
﹤0.01% 310
2017
Q4
$14.8K Hold
188
﹤0.01% 305
2017
Q3
$15.8K Hold
188
﹤0.01% 314
2017
Q2
$12.3K Hold
188
﹤0.01% 329
2017
Q1
$13.7K Sell
188
-16
-8% -$1.05K ﹤0.01% 330
2016
Q4
$12K Buy
+204
New +$10.8K ﹤0.01% 341

Other funds holding ADNT

Estabrook Capital Management's ADNT Position: Q2 2019 in Review

Estabrook Capital Management sold out of Adient (ADNT) in Q2 2019, closing a stake of 69 shares — an estimated $894 sold.

Estabrook Capital Management first reported a position in ADNT in Q4 2016 and held it in 10 quarters. The position peaked at $15.8K in Q3 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2019.

  • Estabrook Capital Management reported no remaining Adient position as of Q2 2019 after selling out during the quarter.
  • Estabrook Capital Management sold 69 Adient shares in Q2 2019, an estimated $894.
  • Estabrook Capital Management first reported a position in Adient in Q4 2016 and held it in 10 quarters.
  • Estabrook Capital Management's Adient position peaked at $15.8K in Q3 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2019.

Based on Estabrook Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.